4th GPCRs-Targeted Drug Discovery Summit

The 4th GPCR-Targeted Drug Discovery Summit: Transforming the Discovery of Novel GPCR-Targeted Therapies.

With positive clinical read outs by Tectonic Therapeutics and recent funding rounds for Confo Therapeutics & Septerna, the potential for novel GPCR drug classes to treat a plethora of diseases grows. Now more than ever, there is a need for the community to come together to share scientific advancements and collaboration opportunities across the full spectrum of GPCR drugs, from small molecules to therapeutic proteins and antibodies.